How Atara Biotherapeutics, Inc. stacks up

ATRA · against 454 other Healthcare companies listed in US-listed

Growth

58/ 100

Below the middle of the pack.

Ranked #255 of 455 · scores higher than 43% of peers

Bars: peers in each 10-point band of the growth score

45 peers with a growth score of 50–59, including ATRA · Click a bar to see the companies

Why growth scores 58?

Weighted metrics compared with all Healthcare companies.

A mix: stronger 3-year revenue growth, but weaker revenue growth than most Healthcare peers.

slower revenue growth over the last year: weaker than 80% of peers. Revenue growth: -6.3% vs peer median 6.1%
Earnings per share growth is not reported, so it is left out of the score.
faster revenue growth over three years: stronger than 84% of peers. 3-year revenue growth: 23.9% vs peer median 5.8%

Metric by metric

Position: dot = ATRA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	ATRA	Peer median	Better than	Position among peers	Weight
Revenue growthHigher is better · 475 reported	-6.3%	11.0%	16%		33%
Earnings per share growthHigher is better · 171 reported	Not reported	21.2%	—	—	33%
3-year revenue growthHigher is better · 433 reported	23.9%	11.0%	71%		33%

A metric that is not reported is left out of the score; the other weights are rescaled.

Ranking by growth score

Top 5 and the companies ranked around ATRA

Rank	Company	Market cap	Growth	Overall
1	Phathom Pharmaceuticals, Inc.PHAT · US-listed	464M USD	100	53
2	AnaptysBio, Inc.ANAB · US-listed	1.4B USD	99	73
2	CorMedix Inc.CRMD · US-listed	433M USD	99	81
2	ImmunityBio, Inc.IBRX · US-listed	8.8B USD	99	31
2	Insight Molecular Diagnostics Inc.IMDX · US-listed	90M USD	99	27
⋯
250	Enovis CorporationENOV · US-listed	1.2B USD	59	46
250	IRADIMED CORPORATIONIRMD · US-listed	1.0B USD	59	74
250	NovoCure LimitedNVCR · US-listed	1.6B USD	59	30
250	Smith & Nephew plcSNN · US-listed	12.6B USD	59	55
255	Atara Biotherapeutics, Inc.ATRA · US-listed	82M USD	58	27
255	Encompass Health CorporationEHC · US-listed	13.3B USD	58	59
255	Humana Inc.HUM · US-listed	50.2B USD	58	49
255	IDEXX Laboratories, Inc.IDXX · US-listed	52.9B USD	58	57
255	Merit Medical Systems, Inc.MMSI · US-listed	5.0B USD	58	60

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…